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Genome-wide association studies and physiological investigations have linked alterations
in acid-base transporters to hypertension. Accordingly, Na+-coupled HCO−3 -transporters,
Na+/H+-exchangers, and anion-exchangers have emerged as putative mechanistic
components in blood pressure disturbances. Even though hypertension has been studied
extensively over the last several decades, the cause of the high blood pressure has
in most cases not been identified. Renal, cardiovascular, and neuronal dysfunctions all
seem to play a role in hypertension development but their relative importance and mutual
interdependency are still being debated. Multiple functional and structural alterations
have been described in patients and animals with hypertension but it is typically unclear
whether they are causes or consequences of hypertension or represent mechanistically
unrelated associations. Perturbed blood pressure regulation has been demonstrated
in several animal models with disrupted expression of acid-base transporters; and
reciprocally, disturbed acid-base transport function has been described in hypertensive
individuals. In addition to regulating intracellular and extracellular pH, Na+-coupled
HCO−3 -transport, Na
+/H+-exchange, and anion-exchange also contribute to water and
electrolyte balance in cells and systemically. Since acid-base transporters are widely
expressed, alterations in transport activities likely affect multiple cell and organ functions,
and it is a significant challenge to determine the mechanisms linking perturbed acid-base
transport function to hypertension. It is the purpose of this review to evaluate the current
evidence for involvement of acid-base transporters in hypertension development and
discuss the cellular and integrative mechanisms, which may link changes in acid-base
transport to blood pressure disturbances.
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INTRODUCTION
Around 40% of the adult population has hypertension (WHO,
2013), and although the cause of the high blood pressure is typi-
cally unknown, it is well established that hypertension is a leading
cause of e.g., ischemic heart disease, stroke, and renal disease.
Consequently, hypertension has detrimental effects on human
health and severe socioeconomic consequences.
Blood pressure control takes place through a complex inter-
play between multiple organ systems. The mean perfusion pres-
sure of the systemic circulation is determined by the product of
the cardiac output and the peripheral vascular resistance; and
consequently, the blood pressure depends on e.g., the cardiac
contractile function, the circulating blood volume, the vascular
smooth muscle and endothelial function in resistance arteries,
the vascular structure, the viscosity of the blood, the secretory
function of endocrine glands, and the sympathetic nervous tone.
In line with the complex nature of blood pressure regulation,
multiple mechanisms of deregulation have been proposed; and
as described by Page’s mosaic theory, essential hypertension in
most cases is likely to be a multifactorial disease involving several
organ systems in a complex interplay (Page, 1949). In some cases,
however, these diverse changes may have a common denomina-
tor such as changes in oxidative stress or immune cell function
(Harrison, 2013). Frequently described causes for hypertension
involve changes in the kidneys, the resistance vasculature, and the
autonomic nervous system. As discussed in further detail below,
the function of these organs all depends on appropriate levels of
membrane acid-base transport activity. In congruence, over the
last few decades, several experimental investigations and genetic
association studies have proposed that alterations in the expres-
sion and function of acid-base transporters can be involved in
blood pressure deregulation (Table 1). For the most part, how-
ever, the mechanistic background linking disturbed acid-base
transport activity to hypertension is unknown, and it is the
scope of the current review to summarize and discuss possible
pathophysiological mechanisms.
GENETIC ASSOCIATION STUDIES
Multiple associations between genetic polymorphisms in acid-
base transporters and disturbed blood pressure regulation have
been described (Table 1). These studies propose that anion-
exchangers (AE1, AE2), Na+,HCO−3 -cotransporters (NBCe1,
NBCe2, NBCn1) and Na+/H+-exchangers (NHE2, NHE3) can
be involved in hypertension development. It should be noted that
for several of the single nucleotide polymorphisms (SNPs), which
have been shown to correlate with hypertension in some studies,
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Table 1 | Genetic and experimental associations between acid-base
transporters and blood pressure.
Gene name SNP/locus/ Phenotype References
modification
SLC4A1 rs5036 Hypertension Kokubo et al., 2006
rs2857078 Preeclampsia Morrison et al.,
2010
SLC4A2 rs2303934 Hypertension Sõber et al., 2009
SLC4A4 SNP Hypertension Yang et al., 2012
SLC4A5 rs7571842
rs10177833
rs8179526
hcv1137534
Salt-sensitive
hypertension
Barkley et al.,
2004; Hunt et al.,
2006; Taylor et al.,
2009, 2012, 2013;
Carey et al., 2012
Knockout Hypertension Gröger et al., 2012
SLC4A7 rs13082711 Hypertension Ehret et al., 2011
Knockout Resting
hypertension but
protected
against
hypertension to
Ang-II and
L-NAME
Boedtkjer et al.,
2011
SLC9A1 Knockout Hypotension Boedtkjer et al.,
2012
Knockout Protection
against
pulmonary
hypertension
Yu et al., 2008
SLC9A2 SNP No. 4
(intron 6)
Hypertension Iwai et al., 2006
SLC9A3 rs4957061 Preeclampsia Morrison et al.,
2010
Knockout Hypotension Schultheis et al.,
1998; Noonan
et al., 2005
SLC26A4 Knockout Protection
against
mineralocorticoid-
induced
hypertension
Verlander et al.,
2003
Overexpression Cl−-sensitive
hypertension
Jacques et al., 2013
SLC26A6 Knockout Protected
against
fructose-induced
hypertension
Singh et al., 2008
SLC26A9 Knockout Hypertension Amlal et al., 2013
other studies have not been able to confirm the association. This
may in part be due to differences in the investigated population
sizes but may also reflect differences in e.g., ethnicities, gender,
age or co-morbidity—which considering the complexity of blood
pressure regulation may modify the effects of specific gene vari-
ants. Depending on the location of the SNPs, it is possible that
they can alter the function or the expression of the transporters,
but in many circumstances the SNPs described to associate with
hypertension may not themselves be causative but rather be in
linkage disequilibrium with functionally important SNPs resid-
ing within the coding region or in important gene regulatory
elements.
While the observed genetic associations do not themselves pro-
vide mechanistic insight, they are important in elucidating new
targets to be studied experimentally. In some cases, experimental
investigations support the link between the acid-base transporters
and hypertension and provide evidence for a pathophysiologi-
cal mechanism. The importance of NBCn1 for blood pressure
regulation was for instance proposed by a recent genome-wide
association study linking the rs13082711 SNP located 10 kb 5′
of the coding region of SLC4A7 to hypertension (Ehret et al.,
2011), and this finding was concurrently reinforced by an exper-
imental study showing that NBCn1 knockout mice have a com-
plex blood pressure phenotype and an altered vascular function
(Boedtkjer et al., 2011), see section The Resistance Arteries and
Microvasculature. Likewise, multiple studies linking SNPs in
SLC4A5 to salt-sensitive hypertension (Barkley et al., 2004; Hunt
et al., 2006; Taylor et al., 2009, 2012, 2013; Carey et al., 2012) have
been supported by the finding that knockout mice for NBCe2 are
hypertensive (Gröger et al., 2012), see section The Kidneys.
THE KIDNEYS
The kidneys have classically been considered the primary organs
for long-term regulation of blood pressure (Guyton, 1991). The
proposed mechanism of renal blood pressure regulation involves
a feedback system where an excess arterial pressure causes the
kidneys to excrete more salt and water, decreasing the circulat-
ing blood volume, and ultimately reducing the blood pressure
(Guyton, 1991). The relationship between arterial pressures and
urinary salt output has been suggested to be exceptionally steep
and the system has been proposed to have infinite feedback gain
(Guyton, 1991), i.e., it is able to fully compensate any deviation
in blood pressure away from the set-point. This dominating role
of the kidneys for blood pressure regulation has more recently
been investigated in a series of elegant experiments using trans-
genic mice. Focusing specifically on the impact of the renin
angiotensin system, reciprocal cross-transplantations of fully vas-
cularized kidney transplants between AT1A receptor deficient
and wild type mice were performed to determine the relative
importance of AT1A receptors expressed in renal (e.g., the renal
epithelium, the renal vasculature or other renal components)
and extra-renal (e.g., the resistance vasculature, the CNS or the
adrenals) tissues for baseline blood pressure and angiotensin
II induced hypertension. These studies support that the hyper-
tensive effects of angiotensin II are predominantly dependent
on renal AT1A receptors (Crowley et al., 2006). In contrast,
the reduced resting blood pressure observed in AT1A deficient
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mice was found to depend approximately equally on renal and
extra-renal AT1A receptors (Crowley et al., 2005). Although sub-
sequent experiments have shown that selective inactivation of
signaling pathways in the vascular wall can protect against hyper-
tension development (see section The Resistance Arteries and
Microvasculature), these findings support that the kidneys play
a prominent—although not exclusive—role for blood pressure
regulation and hypertension development.
As described above, the kidneys contribute to blood pressure
regulation by modulating body water and electrolyte homeostasis
through the control of urinary excretion. Simplistically, enhanced
Na+ and water retention by the kidneys is expected to increase
the circulating blood volume, increase the venous return to the
heart—and through the Frank-Starling mechanism—to raise the
stroke volume, cardiac output, and blood pressure. However,
while an increased cardiac output has been reported in the
early phases of essential hypertension, cardiac output has been
described to be normal in patients with sustained essential hyper-
tension (Lund-Johansen, 1991). Thus, there seems to be a shift
in hypertensive patients from an early phase with a hyperkinetic
circulation (i.e., increased cardiac output) to an established phase
with an increased total peripheral resistance and a normal car-
diac output. The importance of an increased peripheral resistance
for hypertension induced by salt retention has recently been sup-
ported by the finding that smooth muscle specific abrogation of
the myosin light chain kinase (He et al., 2011) or the G-protein
coupled pathways required for activation of the rho-kinase (Wirth
et al., 2008) attenuates the development of deoxycorticosterone
acetate (DOCA)-salt hypertension. Although the mechanisms
linking disturbed renal salt and water handling and increased
circulating blood volume to an increased peripheral vascular
resistance remain controversial, it is well-documented that renal
Na+ retention leads to hypertension. Acid-base transporters may
play a very significant role both in mediating renal Na+ retention
(see below) and in modifying the subsequent increase in periph-
eral vascular resistance (see section The Resistance Arteries and
Microvasculature).
Acid-base transporters are expressed in all segments of the
nephrons and collecting ducts; and since the actions of many
acid-base transporters involve co- or counter-transport of Na+
and/or Cl−, they can directly influence renal NaCl handling. A
detailed description of the expression patterns and functional
roles of acid-base transporters in the different renal tubular
segments is outside the scope of the current review but the
potential role of Na+-coupled acid-base transporters for blood
pressure regulation is exemplified by the Na+/H+-exchanger
NHE3 (Slc9a3): this transporter—which is expressed in renal
proximal tubules, some thin descending limbs, and in the thick
ascending limbs of the loop of Henle—has been shown to
play a major role for renal Na+ reabsorption, and in congru-
ence, under low to normal NaCl intake, NHE3 knockout mice
are hypotensive (Schultheis et al., 1998; Noonan et al., 2005).
Similarly, transport of acid-base equivalents coupled to Cl− has
been convincingly shown to modify blood pressure: knockout
of the anion-exchanger pendrin (Slc26a4), which contributes
to Cl− reabsorption in the distal nephron (Wall et al., 2004),
has been shown to protect against mineralocorticoid-induced
hypertension (Verlander et al., 2003) while overexpression of
pendrin in the intercalated cells was recently shown to cause
hypertension (Jacques et al., 2013). It should be noted that both
direct effects of increased or reduced acid-base transporter activ-
ity as well as compensatory effects of altered delivery of acid-base,
Na+ or Cl− loads to downstream tubule segments may contribute
to changes in electrolyte homeostasis and blood pressure deregu-
lation. Although further experimental evidence is required to test
this hypothesis, it has for instance been suggested that knock-
out of NBCe2—which is expressed in the renal collecting ducts
(Damkier et al., 2007; Gröger et al., 2012)—causes hypertension
because of a compensatory increase in NBCn1 transport activity
(Gröger et al., 2012). NBCn1 is expressed in the renal medullary
collecting ducts (Boedtkjer et al., 2008) and due to the 1:1 Na+ to
HCO−3 stoichiometry of NBCn1 rather than the 1:2 stoichiometry
of NBCe2, the putative shift from NBCe2- to NBCn1-mediated
HCO−3 reabsorption could increase the concomitant Na+ reab-
sorption and contribute to the raised blood pressure (Gröger
et al., 2012). Consistent with the involvement of renal Na+ reten-
tion in the hypertensive phenotype of NBCe2 deficient mice, two
of the SLC4A5 SNPs associated with hypertension in humans were
also found to associate with salt-sensitivity of the raised blood
pressure (Carey et al., 2012).
In addition to direct effects of the Na+- or Cl−-coupled acid-
base transporters on renal salt retention, changes in intracellular
acid-base balance in the renal epithelium are also likely to affect
other transport systems: numerous ion channels [e.g., the ROMK
K+-channel (Wang et al., 1990; Fakler et al., 1996; Choe et al.,
1997)] and transporters [e.g., the Na+/K+-ATPase (Russell et al.,
1983; Eaton et al., 1984; Breitwieser et al., 1987)] are modulated
by the local pH and may therefore, contribute to salt retention or
wasting as a consequence of disturbed intracellular pH control.
Consistent with an association between acid-base transporters
and blood pressure regulation, altered renal expression lev-
els and acid-base transport function have been reported in
hypertension: Na+/H+-exchange activity has been shown to
be increased in brush border membranes of proximal tubules
from spontaneously hypertensive compared to Wistar-Kyoto
rats (Morduchowicz et al., 1989; Gesek and Schoolwerth, 1991;
Dagher and Sauterey, 1992; Hayashi et al., 1997). Whether this
functional difference is explained by an increased expression
of NHE3 in spontaneously hypertensive rats is controversial
(Hayashi et al., 1997; Sonalker et al., 2004) but the increased
Na+/H+-exchange activity may also be related to a lower expres-
sion of the regulatory protein NHERF1 (Kobayashi et al., 2004).
Na+,HCO−3 -cotransport has also been found to be altered in
hypertensive animals; however, the increased NBCe1 expres-
sion reported in the renal cortex of spontaneously hypertensive
compared to Wistar-Kyoto rats (Sonalker et al., 2004) was not
confirmed in experiments using immortalized proximal tubu-
lar epithelial cells, which showed lower NBCe1 expression and
Na+,HCO−3 -cotransport activity in cells from spontaneously
hypertensive compared to Wistar-Kyoto rats (Pedrosa et al.,
2007). The expression of both NBCe1 and NHE3 has been found
to be increased in the renal cortex of rats with noradrenaline-
induced hypertension (Sonalker et al., 2008). Although it is
currently unclear whether these changes in acid-base transporter
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expression and function are causative, compensatory or unre-
lated to the blood pressure disturbances, they warrant further
experimental study to elucidate their mechanistic relevance.
THE RESISTANCE ARTERIES AND MICROVASCULATURE
The resistance vasculature plays a central role in regulating
peripheral vascular resistance and blood pressure in the short
term, but it has been debated whether primary changes in the
vascular wall can be responsible for sustained blood pressure
disturbances: based on the suggestion by Guyton that the renal
regulation of fluid balance has infinite gain, it has been argued
that a blood pressure rise in response to vasoconstriction will
elicit an enhanced renal water and salt excretion, which will
ultimately normalize blood pressure (Guyton, 1990). As a conse-
quence, long-term blood pressure disturbances should be possible
only if renal fluid control is affected either directly or in response
to changes in renal artery function (Guyton, 1990). Supporting a
role for the vasculature in long-term regulation of blood pressure,
pharmacological agents (e.g., Ca2+ channel blockers) thought to
act primarily on the vascular smooth muscle cells have sustained
blood pressure lowering effects (Fleckenstein et al., 1985); and
over recent years, genetic modifications specific to cells of the vas-
cular wall have been shown to modify blood pressure. Smooth
muscle specific inactivation of Arhgef1 or G12-G13-LARG, impor-
tant for rho-kinase signaling, was for instance shown to protect
against hypertension development during chronic angiotensin II
infusion and DOCA-salt treatment (Wirth et al., 2008; Guilluy
et al., 2010) while smooth muscle specific deletion of the NO-
activated soluble guanylyl cyclase (Groneberg et al., 2010) or
endothelium-specific expression of a dominant negative perox-
isome proliferator-activated receptor (PPAR)-γ (Pelham et al.,
2013) was found to cause hypertension. Also, smooth muscle spe-
cific deletion of Dicer (Albinsson et al., 2011), which is required
for microRNA processing, or of the Na+/Ca2+-exchanger (Zhang
et al., 2010) was shown to cause hypotension. Although the ability
of vasoactive drugs and vascular genetic modifications to change
blood pressure in the long term may be explained by actions on
the renal arteries and therefore, ultimately depend on altered renal
fluid handling, these findings demonstrate that primary modi-
fications of vascular function can alter blood pressure and that
these effects are not fully corrected by compensatory changes in
renal excretory function.
The impact of extracellular acid-base disturbances on the
function of resistance arteries has long been appreciated; and
while the mechanistic background is not comprehensively under-
stood, extracellular acid-base disturbances are assumed to con-
tribute substantially to the metabolic regulation of blood flow.
As a consequence of extracellular acid-base disturbances or as
independent disorders, the intracellular acid-base balance can be
altered in a number of disease conditions and probably as a result
of genetic polymorphisms or mutations in acid-base transporters.
As recently reviewed in detail (Boedtkjer and Aalkjaer, 2012),
intracellular acid-base disturbances have major effects on con-
tractile and relaxant functions of resistance arteries. Three trans-
port systems dedicated to movement of acid-base equivalents
have been described in the plasma membrane of vascular smooth
muscle and endothelial cells: acid extrusion is mediated by the
electroneutral Na+,HCO−3 -cotransporter NBCn1 (Aalkjaer and
Hughes, 1991; Boedtkjer et al., 2006, 2011; Thomsen et al., 2013)
and the Na+/H+-exchanger NHE1 (Boedtkjer and Aalkjaer, 2009;
Boedtkjer et al., 2012), while base extrusion is mediated by
Cl−/HCO−3 -exchange (Aalkjaer and Hughes, 1991; Boedtkjer
et al., 2013). Whereas both NBCn1 and NHE1 contribute to cel-
lular acid extrusion during intracellular acidification, NBCn1 is
the primary acid extrusion mechanism important for control
of resting steady-state intracellular pH in both vascular smooth
muscle and endothelial cells (Boedtkjer et al., 2011, 2012). Hence,
knockout of NHE1 affects steady-state intracellular pH only in the
absence of CO2/HCO
−
3 (Boedtkjer et al., 2012).
We recently showed that knockout of NBCn1 has severe con-
sequences for blood pressure regulation in mice: NBCn1 knock-
out mice are moderately hypertensive at rest (∼10mmHg) but
show reduced blood pressure increases to NO-synthase inhibition
and angiotensin II infusion (Boedtkjer et al., 2011). Association
between genetic polymorphisms in NBCn1 and human hyper-
tension has also been demonstrated (Ehret et al., 2011), see
section Genetic Association Studies. Consistent with the changes
in blood pressure regulation, we showed that sustained intra-
cellular acidification of endothelial cells, whether induced by
knockout of NBCn1 (in the presence of CO2/HCO
−
3 ) or NHE1
(in the absence of CO2/HCO
−
3 ), inhibits basal and acetylcholine-
stimulated NO synthesis and vasorelaxation (Boedtkjer et al.,
2011, 2012; Thomsen et al., 2013). In addition, sustained acid-
ification of vascular smooth muscle cells induced by simi-
lar approaches inhibits rho-kinase-dependent Ca2+-sensitivity
and attenuates myogenic responsiveness and vasoconstriction to
noradrenaline (Boedtkjer et al., 2011, 2012; Thomsen et al., 2013).
The combination of anti-contractile and anti-relaxant effects of
low intracellular pH in the vascular wall likely explains the com-
plex blood pressure phenotype of the NBCn1 knockout mice,
which depending on the activity in the affected signaling pathways
under certain conditions display higher and under other condi-
tions lower blood pressure than wild type mice (Boedtkjer et al.,
2011). Adding to the complexity, the anti-contractile effect of low
intracellular pH in the vascular smooth muscle cells is evident
during sustained (i.e., lasting several minutes to hours) intracel-
lular acidification (Boedtkjer et al., 2006, 2011, 2012), whereas
acute (i.e., taking place within a few tens of seconds) intracel-
lular acidification causes abrupt vasoconstriction (Aalkjaer and
Mulvany, 1988) probably due to competition between H+ and
Ca2+ for buffer binding (Abercrombie and Hart, 1986; Batlle
et al., 1993) and as a result of changes in cellular Ca2+ handling
(Nielsen et al., 1991; Kozak et al., 2005; Restini and Bendhack,
2006). Under both physiological and pathological conditions, sus-
tained changes in intracellular pH and associated anti-contractile
effects are likely to predominate in vivo. Since contraction of
vascular smoothmuscle cells is associated with an increased intra-
cellular acid load (Aalkjaer and Mulvany, 1991), it appears that
a major role of membrane acid-base transport in these cells
is to maintain intracellular pH at a sufficiently alkaline level
that the Ca2+ sensitivity is not reduced. This may be particu-
larly important during sustained contractions when the Ca2+-
sensitivity of the vascular smooth muscle cells is usually increased
(Boedtkjer et al., 2006). Supporting the importance of defending
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the intracellular pH of vascular smooth muscle cells during
contractions, we have recently found that NBCn1 is activated
in a calcineurin-dependent manner by the raised intracellular
[Ca2+] during depolarization or agonist-stimulation (Danielsen
et al., 2013). In addition to the vasomotor effects of intracellu-
lar acidification, we have found that intracellular alkalinization
of endothelial cells—induced by inhibition or reversal of anion-
exchange activity—impedes vasorelaxation by reducing intercel-
lular coupling and endothelium-dependent hyperpolarizations
(Boedtkjer et al., 2013). Although additional investigations are
required to fully determine the pathophysiological significance of
altered acid-base balance in the vascular wall, the recent evidence
highlighted above strongly supports that pH-induced changes
in artery function should be considered a possible mechanistic
component in cardiovascular disease.
Besides changes in artery function, it should be appreciated
that changes in the structure of the vascular wall may contribute
to blood pressure disturbances (Folkow et al., 1958; Sivertsson,
1970; Aalkjaer et al., 1987b). Increased media thickness in the
resistance arteries is a characteristic finding in essential hyper-
tension and carries independent prognostic value (Rizzoni et al.,
2003; Mathiassen et al., 2007). Furthermore, changes in arte-
rial media thickness has been reported in models of disturbed
acid-base transport (Yu et al., 2008; Boedtkjer et al., 2012), but
its putative mechanistic role for blood pressure deregulation is
not comprehensively understood (Boedtkjer and Aalkjaer, 2013).
Further evidence is required to determine the role of intracellu-
lar pH regulation for structural adaptation of the vascular wall
but it should be noted that numerous studies on non-vascular cell
types have demonstrated that acid-base transport particularly by
NHE1 modifies cell proliferation and migration (Pedersen, 2006;
Schwab et al., 2012), which are critical processes underlying struc-
tural plasticity. In addition to structural changes in the resistance
arteries, the disappearance of capillaries and pre-capillary arteri-
oles (a phenomenon known as rarefaction) is important for the
development of hypertension (Humar et al., 2009) and could play
a role in blood pressure disturbances induced by altered acid-
base transport. Although endothelial dysfunction has been shown
to be associated with micro-vascular rarefaction (Humar et al.,
2009), the potential effects of intracellular acid-base disturbances
in the vessel wall on angiogenesis and vessel remodeling need
further investigation.
In additional support of a pathogenic role of acid-base trans-
porters for hypertension development, evidence has been pro-
vided that Na+/H+-exchange activity is increased in vascular
smooth muscle cells of arteries from spontaneously hypertensive
rats compared to Wistar-Kyoto rats (Izzard and Heagerty, 1989;
Scuteri et al., 1995; Orlov et al., 2000). Noteworthy, however,
steady-state intracellular pH did not differ between the vascular
smooth muscle cells from adult hypertensive and normoten-
sive rats under physiological conditions, i.e., in the presence of
CO2/HCO
−
3 (Izzard and Heagerty, 1989; Scuteri et al., 1995).
Conversely, a difference in steady-state intracellular pH in the
presence of CO2/HCO
−
3 was reported between young (5 weeks
old) spontaneously hypertensive and Wistar-Kyoto rats, which
may suggest that the effect of NHE1 over-activity is temporally
variable and could be involved at an early critical time point when
the blood pressure disturbance and abnormal artery structure
develop (Izzard and Heagerty, 1989). Alternatively, it is possi-
ble that NHE1 affects the vascular structure through transport-
independent mechanisms or changes in pH of local restricted
spaces with no discernible effect on global intracellular pH, as
has been demonstrated in other cell types (Ro and Carson, 2004;
Stock and Schwab, 2006). It is also possible that the vascular
effects of NHE1 are secondary to changes in the function of other
organ systems. The finding that NHE1 may act independently of
global intracellular pH in the vascular smooth muscle cells is con-
sistent with our previous data showing that arteries isolated from
NHE1 knockout mice have reduced media thickness compared
to arteries isolated from wild type mice despite no apprecia-
ble difference in steady-state intracellular pH in the presence of
CO2/HCO
−
3 (Boedtkjer et al., 2012).
THE CENTRAL AND AUTONOMIC NERVOUS SYSTEMS
The regulation of sympathetic activity takes place through the
cardiovascular center in the brain stem, which integrates multi-
ple afferent inputs (e.g., from baroreceptors, chemoreceptors, and
areas within the CNS) to control the autonomic output to e.g.,
the heart, kidneys, adrenals, and the resistance vasculature. The
importance of afferent and efferent autonomic innervation for
blood pressure control is underscored by the findings that renal
denervation (Symplicity HTN-1 Investigators, 2011) or electric
stimulation of the baroreceptors (Heusser et al., 2010) are promis-
ing treatment modalities for hypertensive patients not responding
to conventional therapy.
Resistance arteries and veins in some vascular beds [e.g., the
mesenteric (Birch et al., 2008)] are subject to intense sympathetic
innervation while other vascular beds are without appreciable
innervation and controlled primarily by local mechanical and
metabolic factors. Increased sympathetic innervation of arter-
ies has been reported in hypertensive rats (Mangiarua and Lee,
1990; Kunes et al., 1991), and it has been demonstrated that
hypertension in spontaneously hypertensive rats can be pre-
vented by reducing the sympathetic innervation (Brock et al.,
1996). In humans, micro-neurography has been used to assess
the sympathetic nervous activity, and an increased sympathetic
nervous drive has been demonstrated in patients with essen-
tial hypertension and even in young (∼24 years old) individuals
with borderline hypertension (Anderson et al., 1989). In experi-
ments where spill-over of noradrenaline from sympathetic nerves
was assessed, enhanced net-release of noradrenaline was found
in patients with essential hypertension (Esler et al., 1981). In
small arteries isolated from humans with essential hypertension,
indirect evidence has been provided for an increased uptake of
noradrenaline into nerve endings in the vascular wall, both in
untreated individuals with essential hypertension (Aalkjaer et al.,
1987b), in persons genetically predisposed for essential hyper-
tension (Aalkjaer et al., 1987a), and in patients already receiving
antihypertensive treatment (Aalkjaer et al., 1989). Although force
development of isolated small arteries to stimulation of the intra-
mural nerves has been shown to correlate negatively with blood
pressure in a normotensive population (Nielsen et al., 1992),
the current evidence points to sympathetic vasoconstriction as
a contributor to the elevated peripheral resistance in essential
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hypertension and proposes that changes in sympathetic function
is an early pathogenic change, which precedes the development of
established essential hypertension.
Regulation of intracellular pH in the peripheral autonomic
nervous system has not been investigated in any major detail but
seems to have both HCO−3 -dependent and -independent com-
ponents: in cultured sympathetic neurons, Na+/H+-exchange
activity was suggested as the dominating acid extrusion mecha-
nism, though HCO−3 -dependent acid extrusion was also found
to enhance intracellular pH recovery after an intracellular acid
load and to increase steady-state intracellular pH (Tolkovsky
and Richards, 1987). Na+/H+-exchange is also a prominent
mechanism of cellular acid extrusion in the central nervous
system (Chesler and Nicholson, 1985). In addition, multiple
Na+-dependent HCO−3 -transporters contribute to intracellu-
lar pH regulation in both neurons and glial cells: the Na+-
driven Cl−/HCO−3 -exchanger NDCBE was originally cloned
from human brain (Grichtchenko et al., 2001); and function-
ally, Na+-dependent Cl−/HCO−3 -exchange has been shown to
be prominent in both invertebrate neuronal tissue (Boron and
De Weer, 1976; Russell and Boron, 1976; Thomas, 1976) and
mammalian neurons and glia (Schwiening and Boron, 1994;
Shrode and Putnam, 1994). Also the electroneutral Na+,HCO−3 -
cotransporter NBCn1 (Boedtkjer et al., 2008) and NCBE/NBCn2
(Chen et al., 2008) have been shown to be widely expressed
in the cerebral and cerebellar cortex and in multiple subcorti-
cal regions. Consistent with high expression levels in the hip-
pocampus (Boedtkjer et al., 2008), NBCn1 has been functionally
demonstrated in cultured hippocampal neurons (Cooper et al.,
2005). Furthermore, the electrogenic Na+,HCO−3 -cotransporter
NBCe1 has been found to be prominently expressed in rat and
mouse brain (Rickmann et al., 2007; Majumdar et al., 2008)
and functionally demonstrated in both neurons (Svichar et al.,
2011) and glia (Deitmer and Schlue, 1989). With respect to base
extrusion, transcripts for multiple anion-exchangers have been
detected in human brain (Havenga et al., 1994), and anion-
exchange activity has been demonstrated in glial cells (Bourke
et al., 1978) and in neurons (Hentschke et al., 2006). Although
the functional role of acid-base disturbances in the brain is not
comprehensively understood, disturbed acid-base transport in
neurons and glia has been suggested to contribute to activation of
glycolysis in astrocytes (Ruminot et al., 2011) and protect against
depolarization-induced acidification in neurons (Svichar et al.,
2011). Furthermore, a pathophysiological significance of acid-
base transport in the brain has been demonstrated by studies
linking acid-base transport function to altered excitability (Bell
et al., 1999; Hentschke et al., 2006; Jacobs et al., 2008) and neu-
ronal cytotoxicity (Cooper et al., 2009). It is likely that changes
in both local intracellular and extracellular pH play a role for the
effects of the acid-base transporters; and while the functional role
of acid-base balance for control of autonomic nervous function is
presently unclear, the prominent acid-base transport mechanisms
demonstrated in brain regions putatively involved in cardiovas-
cular control underscores the need for studies investigating their
mechanistic importance.
Interestingly, it has been proposed that increased Na+ con-
tent in the body modifies sympathetic nervous activity and alters
blood pressure due to a change in the concentration of Na+
in the cerebrospinal fluid (Blaustein et al., 2012). Transport of
Na+ into or out of the cerebrospinal fluid takes place largely
through the choroid plexus and is partly mediated by acid-
base transporters, including NHE1, AE2, NCBE/NBCn2, NBCn1,
and NBCe2 (Damkier et al., 2010) providing a novel putative
mechanism linking acid-base transport to blood pressure control.
CONCLUSIONS
Increasing evidence suggests that disturbed acid-base transport
function may lead to clinically relevant changes in blood pres-
sure and contribute to hypertension development. Although ini-
tial studies investigating the mechanistic link between acid-base
transport and hypertension development are being conducted,
we are still far from a comprehensive understanding. Additional
studies are therefore required to determine to what extent altered
acid-base transport function contributes to hypertension devel-
opment in humans, whether these effects are due to changes in
acid-base balance or dependent on the co- or counter-transported
ions, which organ systems are primarily responsible for the
changes in blood pressure, and whether the acid-base transport
mechanisms can be exploited for future therapeutic intervention.
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